Cresset Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11M | Buy |
87,650
+85,690
| +4,372% | +$10.8M | 0.05% | 214 |
|
2025
Q1 | $268K | Buy |
1,960
+619
| +46% | +$84.7K | ﹤0.01% | 1358 |
|
2024
Q4 | $205K | Sell |
1,341
-5,533
| -80% | -$846K | ﹤0.01% | 1530 |
|
2024
Q3 | $1.33M | Sell |
6,874
-3,274
| -32% | -$635K | 0.01% | 998 |
|
2024
Q2 | $2.35M | Buy |
10,148
+950
| +10% | +$220K | 0.01% | 629 |
|
2024
Q1 | $1.98M | Sell |
9,198
-1,168
| -11% | -$252K | 0.01% | 631 |
|
2023
Q4 | $2.68M | Buy |
10,366
+4,298
| +71% | +$1.11M | 0.02% | 461 |
|
2023
Q3 | $1.56M | Sell |
6,068
-683
| -10% | -$176K | 0.01% | 627 |
|
2023
Q2 | $1.92M | Buy |
6,751
+5,401
| +400% | +$1.54M | ﹤0.01% | 535 |
|
2023
Q1 | $375K | Sell |
1,350
-1,231
| -48% | -$342K | 0.01% | 566 |
|
2022
Q4 | $599K | Sell |
2,581
-318
| -11% | -$73.8K | 0.01% | 394 |
|
2022
Q3 | $775K | Sell |
2,899
-64
| -2% | -$17.1K | 0.01% | 407 |
|
2022
Q2 | $602K | Sell |
2,963
-607
| -17% | -$123K | 0.01% | 501 |
|
2022
Q1 | $752K | Sell |
3,570
-808
| -18% | -$170K | 0.01% | 484 |
|
2021
Q4 | $1.05M | Sell |
4,378
-339
| -7% | -$81.3K | 0.01% | 441 |
|
2021
Q3 | $1.34M | Buy |
4,717
+1,316
| +39% | +$372K | 0.02% | 313 |
|
2021
Q2 | $1.18M | Sell |
3,401
-383
| -10% | -$133K | 0.02% | 313 |
|
2021
Q1 | $1.06M | Buy |
3,784
+390
| +11% | +$109K | 0.02% | 286 |
|
2020
Q4 | $831K | Sell |
3,394
-926
| -21% | -$227K | 0.01% | 278 |
|
2020
Q3 | $1.23M | Buy |
4,320
+385
| +10% | +$109K | 0.02% | 211 |
|
2020
Q2 | $1.05M | Buy |
3,935
+1,739
| +79% | +$465K | 0.02% | 203 |
|
2020
Q1 | $695K | Buy |
2,196
+736
| +50% | +$233K | 0.02% | 237 |
|
2019
Q4 | $433K | Buy |
1,460
+162
| +12% | +$48K | 0.01% | 326 |
|
2019
Q3 | $302K | Buy |
+1,298
| New | +$302K | 0.01% | 385 |
|
2019
Q2 | – | Sell |
-974
| Closed | -$230K | – | 614 |
|
2019
Q1 | $230K | Buy |
974
+409
| +72% | +$96.6K | 0.01% | 343 |
|
2018
Q4 | $170K | Buy |
+565
| New | +$170K | 0.01% | 236 |
|